Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Standard BioTools Inc. (LAB) had Gross Margin of 48.51% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$19.55M |
|
$-34.69M |
|
$10.07M |
|
$9.48M |
|
$52.49M |
|
$-32.94M |
|
$0.04M |
|
$-32.90M |
|
$-32.90M |
|
$-31.68M |
|
$-31.68M |
|
$-34.69M |
|
$-31.68M |
|
$-32.94M |
|
$-32.03M |
|
382.63M |
|
382.63M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$472.44M |
|
$20.74M |
|
$67.20M |
|
$539.64M |
|
$107.97M |
|
$0.30M |
|
$32.01M |
|
$139.98M |
|
$399.66M |
|
$399.66M |
|
$399.66M |
|
383.61M |
|
| Cash Flow Statement Financials | |
$-73.15M |
|
$35.45M |
|
$-0.05M |
|
$168.82M |
|
$132.01M |
|
$-36.81M |
|
$23.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.38 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
|
Gross Margin |
48.51% |
-168.46% |
|
-168.46% |
|
-- |
|
-168.27% |
|
-177.41% |
|
$-80.98M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.40 |
|
1.44 |
|
62.31 |
|
-7.93% |
|
-7.93% |
|
-5.87% |
|
-7.92% |
|
$1.04 |
|
$-0.21 |
|
$-0.19 |
|